Isolation and characterization of the human prosaposin promoter

Gene

Volumn 218, Issue 1-2, 1998, Pages 37-47

  Sun, Ying ^a   Jin, Peng ^a   Witte, David P ^a   Grabowski, Gregory A ^a  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

Gene expression; Promoter analysis; Regulation of prosaposin gene; ROR ; Sp1

Indexed keywords

PROSAPOSIN; TATA BINDING PROTEIN; TRANSCRIPTION FACTOR SP1;

ARTICLE; DNA FOOTPRINTING; ELECTROPHORETIC MOBILITY; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION;

ANIMALS; BASE SEQUENCE; CELL LINE; DNA; DNA FOOTPRINTING; GENE EXPRESSION REGULATION; GLYCOPROTEINS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); PROTEIN PRECURSORS; RESTRICTION MAPPING; SAPOSINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0032544578     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(98)00391-6     Document Type: Article

References (33)

1. Campana W.M., Hiraiwa M., O'Brien J.S. Prosaptide activities the MARK pathway by a G-protein dependent mechanism essential for enhanced sulfatide synthesis by Schwann cells. FASEB J. 12:1998;307-314.
2. Collard M.W., Sylvester S.R., Tsuruta J.K., Griswold M.D. Biosynthesis and molecular cloning of sulfated glycoprotein 1 secreted by rat Sertoli cells: Sequence similarity with the 70-kilodalton precursor to sulfatide/GM1 activator. Biochemistry. 27:1988;4557-4564.
3. Fredman P., von Holst H., Collins P., Granholm L., Svennerholm L. Sialyllactotetraosylceramide, a ganglioside marker for human malignant gliomas. J. Neurochem. 50:1988;912-919.
4. Fredman P. Gangliosides associated with primary brain tumors and their expression in cell lines established from these tumors. Prog. Brain Res. 101:1994;225-240.
5. Fujita N., Suzuki K., Vanier M.T., Popko B., Maeda N., Klein A., Henseler M., Sandhoff K., Nakayasu H., Suzuki K. Targeted disruption of the mouse sphingolipid activator protein gene: A complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids. Hum. Mol. Genet. 5:1996;711-725.
6. Gavrieli-Rorman E., Grabowski G.A. Molecular cloning of a human co-beta-glucosidase cDNA: evidence that four sphingolipid hydrolase activator proteins are encoded by single genes in humans and rats. Genomics. 5:1989;486-492.
7. Gavrieli-Rorman E., Scheinker V., Grabowski G.A. Structure and evolution of the human prosaposin chromosomal gene. Genomics. 13:1992;312-318.
8. Gillen C., Gleichmann M., Spreyer P., Müller H.W. Differentially expressed genes after peripheral nerve injury. J. Neurosci. Res. 42:1995;159-171.
9. Harzer K., Paton B.C., Poulos A., Kustermann-Kuhn B., Roggendorf W., Grisar T., Popp M. Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: Biochemical signs of combined sphingolipidosis. Eur. J. Pediatr. 149:1989;31-39.
10. Hagen G., Muller S., Beato M., Suske G. Cloning by recognition site screening of two novel GT box binding proteins: a family of Sp1 related genes. Nucleic Acids Res. 20:1992;5519-5525.
11. Hiraiwa M., Soeda S., Kishimoto Y., O'Brien J.S. Binding and transport of gangliosides by prosaposin. Proc. Natl. Acad. Sci. USA. 89:1992;11254-11258.
12. Hiraiwa M., Taylor E.M., Campana W.M., Darin S.J., O'Brien J.S. Cell death prevention, mitogen-activated protein kinase stimulation, and increased sulfatide concentrations in Schwann cells and oligodendrocytes by prosaposin and prosaptides. Proc. Natl. Acad. Sci. USA. 94:1997;4778-4781.
13. Holtschmidt H., Sandhoff K., Fürst W., Kwon H., Schnabel D., Suzuki K. The organization of the gene for the human cerebroside sulfate activator protein. FEBS Lett. 280:1991;267-270.
14. Holtschmidt H., Sandhoff K., Kwon H.Y., Harzer K., Nakano T., Suzuki K. Sulfatide activator protein: Alternative splicing that generates three mRNAs and a newly found mutation responsible for a clinical disease. J. Biol. Chem. 266:1991;7556-7560.
15. Jin P., Sun Y., Grabowski G.A. Role of Sp proteins and RORα in transcription regulation of murine prosaposin. J. Biol. Chem. 273:1998;13208-13216.
16. Kinsley C., Winoto A. Cloning of GT box-binding proteins: A novel Sp1 multigene family regulating T-cell receptor gene expression. Mol. Cell. Biol. 12:1992;4251-4261.
17. Kondoh K., Hineno T., Sano A., Kakimoto Y. Isolation and characterization of prosaposin from human milk. Biochem. Biophys. Res. Commun. 181:1991;286-292.
18. Kotani Y., Matsuda S., Sakanaka M., Kondoh K., Ueno S.-U., Sano A. Prosaposin facilitates sciatic nerve regeneration in vivo. J. Neurochem. 66:1996;2019-2025.
19. Leonova T., Qi X., Benscosme A., Ponce E., Sun Y., Grabowski G.A. Proteolytic processing patterns of prosaposin in insect and mammalian cells. J. Biol. Chem. 271:1996;17312-17321.
20. Nakano T., Sandhoff K., Stumper J., Christomanou H., Suzuki K. Structure of full-length cDNA coding of sulfatide activator, a co-β-glucosidase and two other homologous proteins: Two alternate forms of the sulfatide activator. J. Biochem. 105:1989;152-154.
21. O'Brien J.S., Carson G.S., Seo H.C., Hiraiwa M., Kishimoto Y. Identification of prosaposin as a neurotrophic factor. Proc. Natl. Acad. Sci. USA. 91:1994;9593-9596.
22. O'Brien J.S., Carson G.S., Seo H., Hiraiwa M., Weiler S., Tomich J.M., Barranger J.A., Kahn M., Azuma N., Kishimoto Y. Identification of the neurotrophic factor sequence of prosaposin. FASEB J. 9:1995;681-685.
23. Paton B.C., Schmid B., Kustermann-Kuhn B., Poulos A., Harzer K. Additional biochemical findings in a patient and fetal sibling with a genetic defect in the sphingolipid activator protein (SAP) precursor, prosaposin. Evidence for a deficiency in SAP-1 and for a normal lysosomal neuraminidase. Biochem. J. 285:1992;481-488.
24. Qi X., Qin W., Sun Y., Kondoh K., Grabowski G.A. Functional organization of saposin C: Definition of the neurotrophic and acid β-glucosidase activation regions. J. Biol. Chem. 271:1996;6874-6880.
25. Rafi M.A., Degala G., Zhang X.L., Wenger D.A. Mutational analysis in a patient with a variant from a Gaucher disease caused by SAP-2 deficiency. Somat. Cell Mol. Genet. 19:1993;1-7.
26. Schnabel D., Schröder M., Sandhoff K. Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher disease. FEBS Lett. 284:1991;57-59.
27. Schnabel D., Schröder M., Fürst W., Klein A., Hurwitz R., Zenk T., Weber J., Harzer K., Paton B.C., Poulos A., Suzuki K., Sandhoff K. Simultaneous deficiency of sphingolipid activator proteins 1 and 2 is caused by a mutation in the initiation codon of their common gene. J. Biol. Chem. 267:1992;3312-3315.
28. Sprecher-Levy H., Orr-Urtreger A., Lonai P., Horowitz M. Murine prosaposin: Expression in the reproductive system of a gene implicated in human genetic disease. Cell. Mol. Biol. 39:1993;287-299.
29. Sun Y., Witte D.P., Grabowski G.A. Developmental and tissue specific expression of prosaposin mRNA in murine tissues. Am. J. Pathol. 145:1994;1390-1398.
30. Sun Y., Jin P., Grabowski G.A. The mouse prosaposin locus: Promoter organization. DNA Cell Biol. 16:1997;23-34.
31. Svennerholm L., Boström K., Fredman P., Månsson J.Z., Rosengren B., Rynmark G.-M. Human brain gangliosides: Developmental changes from early fetal stage to advanced age. Biochim. Biophys. Acta. 1005:1989;109-117.
32. Vanier M.T., Holm M., Öhman R., Svennerholm L. Developmental profiles of gangliosides in human and rat brain. J. Neurochem. 18:1971;581-592.
33. Zhang X., Rafi M.A., Degala G., Wenger D.A. Insertion in the mRNA of a metachromatic leukodystrophy patient with sphingolipid activator-1 deficiency. Proc. Natl. Acad. Sci. USA. 87:1990;1426-1430.